Astrocytoma

May 27, 2020

Biotech Brief: Global Glioblastoma Multiforme Drug Market Could Exceed $1.4 Billion by 2025

Jul 12, 2019

Global Adult Malignant Glioma Therapeutics Market Research Report 2019-2024: Merck & Co, Roche, and Pfizer Lead the Competition

Feb 04, 2019

Pacific Neuroscience Institute, Nationwide Site Leader of the MDNA55 Clinical Trial, Offers Final Enrollment for Glioblastoma Patients

Jul 09, 2018

San Diego Gamma Knife Center: Diagnostic Precision Leads to Treatment Precision for Primary Brain Gliomas

Oct 27, 2017

Tocagen Presents Updated Durable Complete Response Data from Phase 1 Trial of Toca 511 & Toca FC in Recurrent High-Grade Glioma

Sep 05, 2017

American Brain Tumor Association Announces New Board Chair and Officers

Aug 22, 2017

Brain Tumor Diagnosis and Treatments Market to Reach U.S.$840.7 Million by 2025; Technological Advancements Augur Well for Future

Aug 01, 2017

ABTA Awards 18 Research Grants to Support Early Career Investigators and High-Impact, Collaborative Brain Tumor Research

Jul 24, 2017

Tocagen Receives European Medicines Agency Priority Medicines (PRIME) Designation for Toca 511 in High Grade Glioma